You searched for "retinovascular"
Insights from the ‘Rb-NET Challenges’ Session: Evolving approaches in global retinoblastoma management
2 April 2025
| Mattan Arazi, Ido Didi Fabian, Nick Astbury, Brenda Gallie (Prof), Covadonga Bascaran, Marcia Zondervan
|
EYE - Paediatrics, EYE - Pathology, EYE - Oncology
The Retinoblastoma Network (Rb-NET) Multidisciplinary Team (MDT) platform, developed by the London School of Hygiene & Tropical Medicine (LSHTM) and Professor Ido Didi Fabian, is a web-based telemedicine initiative that regularly hosts virtual MDT meetings focused on the evaluation and...
Paediatric enucleation in a tertiary eye centre in North China, 2001-2015
The authors review the demography and aetiology of paediatric enucleation over a 15-year period. A total of 9307 paediatric ophthalmic inpatients ranging from 0 to 14 years who underwent surgery at Shandong Eye Institute over the past 15 years were...
Episcleral brachytherapy (EB) for retinoblastoma (RB)
5 June 2020
| Jonathan Chan
|
EYE - Pathology, EYE - Oncology
|
episcleral brachytherapy, focal consolidation therapy, ocular survival, recurrence-free survival, retinoblastoma
This retrospective study consisted of 11 eyes treated either with Iodine (I) -125 or Ruthenium (R) -106EB with a mean apical dose of 44Gy. There were five in group B (46%), three in group C (27%) and three in group...
Top cited 100 publications in paediatric ophthalmology
The author identified the top 100 cited publications in paediatric ophthalmology in an effort to identify which topics are most strongly represented and potential areas where further research is needed. An ISI Web of Science database search was conducted in...Africa makes strides in tackling blinding eye diseases: highlights of annual conference
1 December 2022
| Shaffi Mdala, Chinsisi Namate Nyirenda, Thokozani Zungu, Moira Gandiwa, Muchai Gachago, Nick Astbury, Marcia Zondervan, Covadonga Bascaran
|
EYE - General
Introduction The 9th Annual Scientific Conference of the College of Ophthalmology of Eastern, Central and Southern Africa (COECSA) was held at the Bingu International Convention Centre in Lilongwe, Malawi in September 2022. The meeting was hosted by the Ophthalmological Society...
What not to miss in neuro-ophthalmology Part 1
1 April 2018
|
EYE - Neuro-ophthalmology
Neuro-ophthalmology is a complex and difficult subspecialty in ophthalmology. It has several connections to neurology, neuro-surgery, rheumatology as well as many other medical specialties. Working in an multidisciplinary team (MDT) environment is key to success in this subspecialty as mistakes...
An update on inherited retinal disorders (part 1) – overview and assessment of inherited retinal disease
1 October 2016
| Michel Michaelides (Prof)
|
EYE - Vitreo-Retinal
Part 2 of this topic can be found here Inherited Retinal Disease (IRD) is the leading cause of blindness certification in the working age population (age 16-64 years) in England and Wales and the second most common in childhood [1]....
Vitreomacular traction and full thickness macular hole
Clinical scenario: A 64-year-old lady presented to the clinic with a few weeks history of sudden onset of metamorphopsia, central blur and reduced vision in her right eye. The ocular examination and ocular coherence tomography confirmed right eye focal vitreomacular...More sensitive visual acuity test for age-related macular degeneration
1 October 2016
| Roger S Anderson (Prof), Nilpa Shah
|
EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. Primarily associated with ageing, genetic factors and lifestyle choices such as smoking also play a contributory role. Patients with early AMD, characterised by the development of...
The role of injection assistant devices in establishing a nurse-led AMD service
1 April 2018
| Hani Hasan
|
EYE - Vitreo-Retinal
The author shares his experience of setting up a nurse-led service to deliver anti-VEGF intravitreal injections and how injection assistant devices supported training. Age-related macular degeneration (AMD) has become a leading cause of irreversible blindness [1]. It is estimated that...
Corporate M&A pace gathers momentum
1 October 2019
| Rod McNeil
|
EYE - General
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...
Rb-NET: a network to save life and preserve vision in children in Africa
1 April 2018
| Pippa Williams, Richard Bowman, Allen Foster (Prof), Ido Didi Fabian, Marcia Zondervan
|
EYE - Pathology, EYE - Oncology
Responding to need is a key element underpinning the VISION 2020 LINKS Programme [1]. It is embedded in the process through which LINKS are established, with institutions in low- and middle-income countries (LMICs) first defining their priority areas of training...
